Neoplasms

Symptoms and General Pathology

All Conditions

Wounds and Injuries

Musculoskeletal Diseases

Neoplasm Metastasis

Fractures, Bone

Bone Neoplasms

Patients treated by percutaneous CT-guided procedures in the bone with the EPIONE® device

The EPIONE device is a user controlled, stereotactic accessory intended to assist in the planning and manual advancement of one or more instruments, as well as in verification of instrument position during Computed Tomography (CT) guided percutaneous procedures (thermal ablation, bone consolidation, biopsy procedures).

CT-guided bone percutaneous procedure

Laetitia P Messner

Silène P Launay

Thierry DE BAERE

Interventional clinical study to obtain performance and safety data of the EPIONE® device when used for bone percutaneous procedures.

The Epione device is an image-guided robotized device that assists the physician during CT-guided procedures.

EPIBONE Study: a Prospective Study on Feasibility, Safety and Accuracy

Evaluation of the EPIONE Robotic System for Image-guided Percutaneous Bone Procedures A Prospective Study on Feasibility, Safety and Accuracy

Assessment of the feasibility of the EPIONE robotic system assistance for bone percutaneous procedures based on a definition of conversion to manual technique

Quantum Surgical

Infections

Respiratory Tract (Lung and Bronchial) Diseases

Digestive System Diseases

Urinary Tract, Sexual Organs, and Pregnancy Conditions

COVID-19

Communicable Diseases

Liver Neoplasms

Postoperative Complications

Genital Diseases, Female

Intestinal Neoplasms

Lung Neoplasms

Genital Diseases

Gastrointestinal Neoplasms

Digestive System Neoplasms

Gastrointestinal Diseases

Pneumonia

Pneumonia, Viral

Respiratory Tract Infections

Virus Diseases

Coronavirus Infections

Coronaviridae Infections

Nidovirales Infections

RNA Virus Infections

Lung Diseases

Respiratory Tract Diseases

Intestinal Diseases

Urogenital Diseases

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Respiratory Tract Neoplasms

Thoracic Neoplasms

no intervention

Diansan Su, MD,PHD

To explore the relationship between SARS-CoV-2 infection in different time before operation and postoperative main complications (mortality, main pulmonary and cardiovascular complications) 30 days after operation; To determine the best timing of surgery after SARS-CoV-2 infection.

A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection

Main Postoperative Complications After SARS-CoV-2 Infection: A Retrospective Cohort Study

All-cause mortality at 30 days after operation

a composite of postoperative pneumonia, acute respiratory distress syndrome (ARDS) and unexpected ventilation

a composite of cardiogenic death, myocardial infarction, new-onset heart failure or cardiogenic shock, and cerebrovascular accident (CVA)

The First Affiliated Hospital of Anhui Medical University

First Affiliated Hospital of Chongqing Medical University

Sichuan Academy of Medical Sciences

Second Hospital of Shanxi Medical University

RenJi Hospital

Nervous System Diseases

Behaviors and Mental Disorders

Rare Diseases

Rectal Neoplasms

Prostatic Neoplasms

Stomach Neoplasms

Colonic Neoplasms

Delirium

Urinary Bladder Neoplasms

Sigmoid Neoplasms

Kidney Neoplasms

Emergence Delirium

Confusion

Neurobehavioral Manifestations

Neurologic Manifestations

Neurocognitive Disorders

Mental Disorders

Psychotic Disorders

Genital Neoplasms, Male

Urogenital Neoplasms

Genital Diseases, Male

Prostatic Diseases

Male Urogenital Diseases

Stomach Diseases

Liver Diseases

Colorectal Neoplasms

Rectal Diseases

Urologic Neoplasms

Urinary Bladder Diseases

Urologic Diseases

Colonic Diseases

Kidney Diseases

Sigmoid Diseases

Stomach Cancer

Adjuvants, Anesthesia

Analgesics

Central Nervous System Depressants

All Drugs and Chemicals

Antiemetics

Psychotropic Drugs

Gastrointestinal Agents

Fentanyl

Droperidol

Droperidol 1.25 mg and fentanyl 0.025 mg (diluted with normal saline up to 5ml) is to be administrated intravenously 30 minutes before the end of the procedure.

The same volume of normal saline is to be administrated intravenously 30 minutes before the end of the procedure.

low-dose neuroleptanalgesia

Placebo

Diansan Su, Doctor

Zhenling Huang, Doctor

Xiao Zhang, MS

Cuixia Song, BS

Postoperative delirium（POD）is a common complication that can directly affect important clinical outcomes, and exert an enormous burden on patients, their families, hospitals, and public resources. In order to evaluate whether an intraoperative administration of low-dose neuroleptanalgesia reduces postoperative delirium, droperidol 1.25 mg and fentanyl 0.025 mg or normal saline is used by intravenous injection 30 minutes before the end of the operation, in elderly patients with non-cardiac major surgery under general anesthesia. The efficiency and safety of neuroleptanalgesia on the incidence of POD would be evaluated in elderly patients.

Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients

Low-dose Neuroleptanalgesia Reduce the Occurrences of Postoperative Delirium in Elderly Patients Undergoing Non-cardiac Major Surgery : a Randomized Controlled Trial

This outcome will be measured using a numeric rating scale from 1 ( dissatisfaction ) to 3 (very satisfied)

Shanghai 8th People's Hospital

Main Postoperative Complications After COVID-19

Main Postoperative Complications After SARS-CoV-2 Infection: A Prospective Cohort Study

a composite of myocardial infarction, new-onset heart failure or cardiogenic shock, deep vein thrombosis (DVT), pulmonary embolism (PE), and cerebrovascular accident (CVA)

Skin and Connective Tissue Diseases

Breast Neoplasms

Brain Diseases

Central Nervous System Diseases

Breast Diseases

Skin Diseases

The experiment is conducted on 10 types of studies with AI:

1. Chest CT/ LDCT with different pathologies;
2. Abdominal CT with different pathologies;
3. Head CT with different pathologies;
4. MSS XR with different fractures
5. Spine XR with different pathologies;
6. MMG;
7. Brain MRI with different pathologies;
8. Cervical spine MRI, Lumbosacral spine MR and Thoracic spine MRI with spine pathologies
9. Knee joint MRI
10. Lesser pelvis MRI.

The experiment is conducted on 10 types of studies without AI:

1. Chest CT/ LDCT with different pathologies;
2. Abdominal CT with different pathologies;
3. Head CT with different pathologies;
4. MSS XR with different fractures
5. Spine XR with different pathologies;
6. MMG;
7. Brain MRI with different pathologies;
8. Cervical spine MRI, Lumbosacral spine MR and Thoracic spine MRI with spine pathologies
9. Knee joint MRI
10. Lesser pelvis MRI.

Kirill Arzamasov, PhD

Olga Omelyanskaya

Anton Vladzymyrskyy

It is planned to integrate various services based on computer vision technologies for analysis of the certain type of x-ray study into Moscow Unified Radiological Information Service (hereinafter referred to as URIS).

As a result of using computer vision-based services, it is expected:

1. Reducing the number of false negative and false positive diagnoses;
2. Reducing the time between conducting a study and obtaining a report by the referring physician;
3. Increasing the average number of radiology reports provided by a radiologist per shift.

Recently a growth in the number of radiology studies across multiple modalities has been observed alongside the modest increase in staffing levels. This carries higher risks of increased workload and efficiency losses. The integration of computer vision-based services into URIS will improve the radiologists' productivity and job performance.

Existing prerequisites for conducting the study:

1. Increasing the number of preventive and diagnostic radiological studies entails the growing workload for radiologists and increased risk of interpretation errors, which in turn leads to the decrease in quality of medical care.
2. When a radiologist opens a worklist of studies, in the absence of special notes, he/she writes a report in the random order, not being able to select from the list the studies that require the most attention and prompt response (studies with pathological findings), which increases the time of diagnosis.
3. The absence of the structured pre-filled template of report leads to the increase in time for preparing reports.
4. A radiologist has to spend considerable time evaluating the dynamics of pathological changes, which also increases the time to prepare a report as well as the risk of error.
5. Interpretation of preventive studies requires double reading, which is implemented inefficiently due to the staff shortage.

Study objectives:

1. Study the diagnostic accuracy of the Services in accordance with the methodological guidelines No. 43 "Clinical trials of software based on intelligent technologies (diagnostic radiology)" (recommended by the Expert Council on Science of the Moscow Healthcare Department, Protocol No. 8 of June 25, 2019).
2. Audit the studies conducted with Services application in order to determine the number of interpretation errors, and compare it with the audit result without their application (hypothesis 1).
3. Conduct timekeeping to estimate time for preparing a report and the total number of evaluated studies with and without using the Services (hypothesis 2,3).
4. Conduct a survey of radiologists who use the Services in their work, in order to determine their opinion about the implementation of innovative technologies in the diagnostic process.

METHODOLOGY

1. The Experiment is carried out by the Moscow Healthcare Department in accordance with Regulation No. 43 of January 24, 2020 "On approval of the procedure and conditions for conducting the Experiment on the use of innovative computer vision technologies for analysis of medical images and further application in Moscow healthcare system".
2. The experiment is conducted on the next types of studies:

1)Detection of CT signs consistent with COVID-19 (coronavirus) lung involvement (Chest CT); 2) Emphysema extent (Chest CT); 3) Detection of CT signs consistent with malignant neoplasm in the lungs (Chest CT); 4) Detection of LDCT signs consistent with malignant neoplasm in the lungs (Chest LDCT); 5) Detection and localization of compression vertebral fractures with a degree of vertebral body deformity of over 25% according to the Genant semi-quantitative scale, grades 2-3 (Chest CT); 6) Detection of free pleural fluid (effusion) (Chest CT); 7) Detection of enlarged intrathoracic lymph nodes (lymphadenopathy) (Chest CT); 8) Detection of bronchiectasis (Chest CT); 9) Detection of CT signs consistent with pulmonary tuberculosis (Chest CT); 10) Coronary calcium score (Chest CT/ LDCT); 11) Paricardial fat volume (Chest CT); 12) Dilation of ascending and descending thoracic aortas (Chest CT/ LDCT); 13) Dilation of the pulmonary trunk (Chest CT/ LDCT); 14) Detection of sarcoidosis (Chest CT); 15) Detection of signs consistent with the impairment of lung airness (Chest CT); 16) Detection of signs consistent with the focal lesions in the chest bones (Chest CT); 17) Detection of CT signs consistent with rib fracture (Chest CT); 18) Detection of signs of urolithiasis (Abdominal CT); 19) Detection of signs consistent with the focal lesions in the skeleton bones (Abdominal CT); 20) Detection of liver lesions (Abdominal CT); 21) Detection of CT signs consistent with gallbladder stones (Abdominal CT); 22) Detection of CT signs consistent with renal lesions (Abdominal CT); 23) Measuring the abdominal aorta dilation (Abdominal CT); 24) Detection of adrenal lesions (Abdominal/Chest CT); 25) Detection and localization of compression vertebral fractures with a degree of vertebral body deformity of over 25% according to the Genant semi-quantitative scale, grades 2-3 (Abdominal CT); 26) Automation of routine liver measurements (dimensions, liver density, choledochus diameter, portal vein diameter) (Abdominal CT); 27) Automation of routine kidney measurements (kidney size, pelvicalyceal system size) (Abdominal CT); 28) Automation of routine measurements of spleen and pancreas (size, density of the spleen and pancreas) (Abdominal CT); 29) Detection of acute ischemic stroke and its ASPECTS score (Head CT); 30) Detection of hemorrhage and its automatic volume calculation in ml or cm³ (Head CT); 31) Automation of routine measurements (ventriculometry, displacement of median structures, measurement of the craniovertebral junction) (Head CT); 32) Detection and localization of (at least 7) signs consistent with the priority disease (Chest XR); 33) Detection of signs (at least one) consistent with bone fracture (MSS XR); 34) Detection of radiologic signs (at least one) consistent with arthrosis of the joints (MSS XR); 35) Detection of radiological signs (at least one) consistent with deforming arthrosis of the hip (MSS XR); 36) Detection of radiological signs (at least one) consistent with the fracture of the shoulder joint bones (MSS XR); 37) Detection of radiological signs (at least one) consistent with the fracture of the hip joint bones (MSS XR) 38) Detection of radiological signs (at least one) consistent with the fracture of the ankle joint bones (MSS XR).

39) Detection of reduced pneumatization / opacity of the paranasal sinuses (Head XR) 40) Detection of signs (at least one) consistent with transverse flat foot (MSS XR) 41) Detection of signs (at least one) consistent with the longitudinal flat foot in the lateral plane (MSS XR); 42) Detection of the signs of osteoporosis: detection and localization of compression vertebral fractures with a degree of height loss of over 25% as well as the radio density measurements of vertebral bodies (Spine XR); 43) Detection of signs consistent with osteochondrosis in the frontal and/or sagittal plane (Spine XR); 44) Detection of signs consistent with scoliosis in the frontal plane (Spine XR); 45) Detection of signs consistent with spondylolisthesis in the sagittal plane (Spine XR); 46) Detection and localization of findings consistent with breast cancer (MMG); 47) Detection of multiple sclerosis (Brain MRI); 48) Detection and localization of intracranial neoplasms (extracerebral, intracerebral) (Brain MRI); 49) Automation of routine measurements (ventriculometry, displacement of median structures, measurement of the craniovertebral junction, changes in white matter, intracranial measurements) (Brain MRI); 50) Detection of signs consistent with the focal lesions in the cervical spinal cord (Cervical spine MRI); 51) Detection and localization of MRI signs (at least one) consistent with degenerative changes in the cervical discs on sagittal and axial T2-WI (Cervical spine MRI); 52) Detection and localization of MRI signs (at least one) consistent with degenerative changes in the thoracic discs on sagittal and axial T2-WI (Thoracic spine MRI); 53) Detection of signs consistent with the focal lesions in the thoracic spinal cord (Thoracic spine MRI); 54) Detection and localization of MRI signs (at least one) consistent with degenerative changes in the lumbosacral discs on sagittal and axial T2-WI (Lumbosacral spine MRI); 55) Detection of signs consistent with the focal lesions in the lumbosacral spinal cord (Lumbosacral spine MRI); 56) Detecting signs consistent with the areas of cartilage breakdown (chondromalacia) along the articular surfaces of the knee and the patellofemoral joint (Knee joint MRI); 57) Automated routine measurements of the prostate gland (dimensions) (Lesser pelvis MRI); 58) Automated routine measurements of the uterus (corpus and cervix: position, dimensions, displacements) (Lesser pelvis MRI).

3. For each Service during the Experiment, a certain number of studies is provided for processing based on their type:

1. CT/LDCT - 30 250 studies;
2. XR - 55 000 studies;
3. MMG - 48 500 studies;
4. MRI - 22 500 studies.

4. A methodology for including services in the Experiment has been developed. For each Service, the participation process in the Experiment consists of the following stages:

1. selection;
2. the preparatory stage;
3. the main stage;
4. the final stage.

During the Experiment, a radiologist will routinely be able to:

* work on a sorted list of patients (triage);
* work with images processed by the Service;
* work with a pre-filled template of the radiological report on each study;
* evaluate the work of the Service according to the developed questionnaire. During the Experiment, a patient will receive the individual plan of the follow-up support. It includes preventive examinations or observation as well as treatment by a specialist.

Systematization and final analysis of the Experiment results is carried out within three months from the completion date of the last Service participation in the Experiment.

Based on the results of the Experiment, recommendations can be prepared on the possibility to register certain services as a medical device (software).

Experiment on the Use of Innovative Computer Vision Technologies for Analysis of Medical Images in the Moscow Healthcare System

Change of at least 30% in the number of errors in interpretation of the studies with using computer vision-based services compared to the number of errors in interpretation without their application.

Change of at least 30% of the time from the study completion to report finalization by a radiologist.

Change of at least 30% in the number of radiology reports provided by a radiologist per shift.

Change of at least 30% in computer vision-based services errors as per integrated feedback form for radiologists in the PACS.

Types of errors:

1. Technological defect (absent AI-generated series, partially generated AI series, DICOM SR and images mismatch, multiple conflicting results)
2. Major discrepancy (findings outside the region of interest, irrelevant findings)
3. Inaccurate diagnosis
4. Inaccurate lesion localisation
5. Inaccurate lesion classification
6. Other (free-text field)

Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
EPIBONE Study: a Prospective Study on Feasibility, Safety and Accuracy	NCT06376682	Bone Metastases Fractures, Bone Bone Tumor	CT-guided bone ...	18 Years -	Quantum Surgical
A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection	NCT05781581	Intestines Canc... Pulmonary Cance... Liver Cancer Trauma Fractures, Bone Gynecologic Dis...	no intervention	18 Years -	RenJi Hospital
Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients	NCT05068180	Stomach Neoplas... Colonic Neoplas... Rectal Neoplasm... Sigmoid Neoplas... Liver Neoplasms Kidney Neoplasm... Urinary Bladder... Prostatic Neopl... Osteoarthropath... Fractures, Bone Gynecologic Can...	low-dose neurol... Placebo	65 Years - 85 Years	RenJi Hospital
A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection	NCT05781581	Intestines Canc... Pulmonary Cance... Liver Cancer Trauma Fractures, Bone Gynecologic Dis...	no intervention	18 Years -	RenJi Hospital
Main Postoperative Complications After COVID-19	NCT05694949	Intestines Canc... Pulmonary Cance... Liver Cancer Trauma Fractures, Bone		18 Years -	RenJi Hospital
Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients	NCT05068180	Stomach Neoplas... Colonic Neoplas... Rectal Neoplasm... Sigmoid Neoplas... Liver Neoplasms Kidney Neoplasm... Urinary Bladder... Prostatic Neopl... Osteoarthropath... Fractures, Bone Gynecologic Can...	low-dose neurol... Placebo	65 Years - 85 Years	RenJi Hospital
Experiment on the Use of Innovative Computer Vision Technologies for Analysis of Medical Images in the Moscow Healthcare System	NCT04489992	AI (Artificial ... Mammary Cancer Lung Cancer X-Rays; Lesion COVID-19 Chest--Diseases Abdomen Disease Brain Disease Fractures, Bone		18 Years -	Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department
Main Postoperative Complications After COVID-19	NCT05694949	Intestines Canc... Pulmonary Cance... Liver Cancer Trauma Fractures, Bone		18 Years -	RenJi Hospital

Spots Global Cancer Trial Database for fractures, bone